The purpose of this study was to assess the significance of tenascin-C (Tnc) expression in steatotic liver ischemia/reperfusion injury (IRI). The critical shortage in donor organs has led to the use of steatotic livers in transplantation regardless of their elevated susceptibility to hepatic IRI. Tnc is an endogenous danger signal extracellular matrix molecule involved in various aspects of immunity and tissue injury. In the current study, mice were fed with a steatosis-inducing diet and developed approximately 50% hepatic steatosis, predominantly macrovesicular, before being subjected to hepatic IRI. We report here that lipid accumulation in hepatocytes inflated the production of Tnc in steatotic livers and in isolated hepatic stellate cells. Moreover, we show that the inability of Tnc-/-deficient steatotic mice to express Tnc significantly protected these mice from liver IRI. Compared with fatty controls, Tnc-/-steatotic mice showed significantly reduced serum transaminase levels and enhanced liver histological preservation at both 6 and 24 hours after hepatic IRI. The lack of Tnc expression resulted in impaired lymphocyte antigen 6 complex, locus (Ly6G) neutrophil and macrophage antigen-1 (Mac-1) leukocyte recruitment as well as in decreased expression of proinflammatory mediators (interleukin 1β, tumor necrosis factor α, and chemokine [C-X-C motif ] ligand 2) after liver reperfusion. Myeloperoxidase (MPO) is the most abundant cytotoxic enzyme secreted by neutrophils and a key mediator of neutrophil-induced oxidative tissue injuries. Using an in vitro model of steatosis, we also show that Tnc markedly potentiated the effect of steatotic hepatocytes on neutrophil-derived MPO activity. In conclusion, our data support the view that inhibition of Tnc is a promising therapeutic approach to lessen inflammation in steatotic livers and to maximize their successful use in organ transplantation.
Hepatic ischemia/reperfusion injury (IRI) is a pathological condition characterized by an initial insult caused by the restriction of blood supply to the liver, which is further accentuated by the restoration of blood flow to the compromised organ. (1) Hepatic IRI remains a major clinical limitation in orthotopic liver transplantation, (2) and its negative impact is highly aggravated in steatotic livers. (3) (4) (5) (6) Steatosis, characterized by the deposition of triglyceride-rich lipid droplets in the cytoplasm of hepatocytes, is a global health problem affecting a very large number of potential donor livers. (7) (8) (9) (10) (11) Steatosis when present in moderate to severe levels (>30%), particularly macrosteatosis, (6) leads to elevated rates of primary nonfunction (12) and decreased graft and patient survival after transplantation. (13) Nevertheless, the shortage of organ donors has led to the use of these suboptimal steatotic livers in transplantation. (8, 9) In 2015 alone, ~2900 patients died on, or were removed from (because of further health deterioration), the waiting list before having a chance
Original article | 289 to undergo liver transplantation. (14) Hence, there is a need for finding protective strategies effective in fatty liver IRI. Tenascin-C (Tnc) is a large hexameric extracellular matrix (ECM) molecule composed of multiple fibronectin-type III and epidermal growth factorlike repeats and a single fibrinogen-like domain. (15) Tnc is abundantly expressed during embryogenesis and is normally undetectable in most healthy adult tissues. (15) Notably, Tnc is rapidly induced in adult tissues in response to pathological stress. (16) Although Tnc is necessary for physiological tissue repair, its misregulated expression has been associated with a variety of pathological conditions, which include rheumatoid arthritis, cancer, myocardial infarction, hepatitis, and hepatic IRI. (17) (18) (19) (20) (21) (22) Tnc is a pleiotropic molecule implicated in various cellular functions, with regulation of cell adhesion and migration being among the most characterized. (18) Growing evidence now points to Tnc as a key regulator of both innate and adaptive immunity. A number of studies have reported that Tnc affects leukocyte recruitment, T cell activation and proliferation, and the production of several inflammatory cytokines. (17, 18, (23) (24) (25) (26) Tnc is an immunomodulatory protein with complex tissue-specific interactions and functions, which are dependent on the type of tissue injury. (22, 24) Normal and steatotic livers undergo different mechanisms of ischemic injury. (4) The present study assesses the effect of hepatic lipid accumulation on Tnc expression, and it tests whether Tnc deletion ameliorates the outcome of steatotic liver IRI.
Materials and Methods

aniMals, Diet, anD MODel OF Hepatic iri
Tnc-deficient (Tnc-/-) knockout mice (C57BL/6N-TgH) were obtained from Riken, Japan, (27) rederived by sterile embryo transfer to surrogate mothers, and housed in the University of California, Los Angeles, animal facility under specific pathogen-free conditions. To achieve hepatic steatosis, Tnc-/-mice and matched Tnc+/+ wild-type (WT) littermates were fed a high-fat diet (HFD; 60% kcal in fat; Research Diets, D12492) from 4 to 12 weeks of age, as previously described. (28) Twelve-week-old male mice were subjected to hepatic IRI according to previously published surgical procedures. (28, 29) Briefly, arterial and portal venous blood supplies were interrupted to the cephalad lobes of the liver for 60 minutes using an atraumatic clip, and mice were killed after reperfusion. All animals received humane care according to the criteria outlined in the Guide for the Care and Use of Laboratory Animals published by the National Institutes of Health (publication 1985) .
serUM transaMinases
Serum alanine transaminase (ALT) and serum aspartate transaminase (AST) levels were measured using a commercially available kit (Teco Diagnostics, Anaheim, CA), according to the manufacturer's instructions.
HistOlOgY anD iMMUnOHistOcHeMistrY
Liver histology and immunohistochemistry were performed in paraffin or cryostat sections as previously published. (28) Liver specimens were fixed with a 10% formalin-buffered solution (FBS), embedded in paraffin, and processed for hematoxylin-eosin (H & E) staining. To access the percentage of steatosis, livers were fixed in 4% paraformaldehyde in phosphatebuffered saline, embedded in an optimal cutting temperature compound, and processed for Oil Red O staining. Immunohistochemistry was performed using Mac-1 (M1/70) and lymphocyte antigen 6 complex, locus G (Ly6G; 1A8) from BD Biosciences, matrix metalloproteinase 9 (MMP9; AF909; R&D Systems, Minneapolis, MN), and Tnc (MTn-12: Abcam, Burlingame, CA) antibodies at optimal dilutions. (30) Reverse transcription was performed using 5 μg of total RNA in a first-strand complementary DNA (cDNA) synthesis reaction with SuperScript III RNaseH Reverse Transcriptase (LifeTechnologies), as recommended by the manufacturer. The cDNA product was amplified by reverse-transcription polymerase chain reaction (RT-PCR) using primers specific for each target cDNA.
isOlatiOn anD cUltUre OF MOUse cells
Isolation of neutrophils, hepatocytes, and HSCs was performed according to previously published methods. (30) (31) (32) Briefly, to isolate primary murine hepatocytes and HSCs, anesthetized mice were subject to a midline laparotomy and cannulation of the inferior vena cava followed by liver perfusion with an ethylene glycol tetraacetic acid-chelating perfusion buffer ( 3 , 350 mg/L; and collagenase P, 400 mg/L), livers were minced and cells were dispersed in culture medium. Hepatocyte and nonparenchymal cells were separated by low-speed centrifugation methods. After isolating hepatocytes, HSCs were then purified from nonparenchymal cells using a Nicodenz gradient (8%, 1500 g). Purified HSCs were resuspended in the Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% FBS. To isolate adult murine neutrophils, mouse femurs and tibias were stripped of all muscle and sinew, and bone marrow was flushed with Hank's balanced salt solution (HBSS). Cells were pelleted, and erythrocytes were removed by hypotonic lysis. The bone marrow preparation was resuspended at 5 × 10 7 cells/mL in HBSS, and the cells were layered on a Percoll gradient (Sigma-Aldrich, St. Louis, MO). Mature neutrophils were recovered at the interface of the 65% and 80% fractions and were >90% pure and >95% viable in the neutrophil-rich fraction.
HepatOcYte-cOnDitiOneD MeDiUM preparatiOn anD Hsc activatiOn in vitrO
The preparation of a palmitic acid (PA; P0500, Sigma) stock solution and a palmitate-induced in vitro fatty liver model were carried out as previously described. (33) Briefly, isolated mouse hepatocytes (2 × 10 5 cells/well) were incubated with DMEM plus 10% FBS for 12 hours and then treated with or without 400 µM of PA for 24 hours to induce intracellular lipid accumulation. The supernatants were clarified by centrifugation at 6000g to remove cell debris, filtered, and stored in aliquots at −80°C until use. Supernatants harvested from control and steatotic hepatocytes were used as hepatocyte-conditioned medium (HCM) and steatotic hepatocyte-conditioned medium (S-HCM), respectively. HSCs (10 × 10 4 cells/well) were stimulated with HCM or S-HCM for 24 hours. In additional experiments, isolated primary HSCs were stimulated for 24 hours with varying concentrations of recombinant mouse interleukin (IL) 1β (1, 5, and 10 ng/mL; EMD Millipore, Temecula, CA). After stimulation, cell samples were harvested either for RNA isolation or for immunofluorescence staining.
MYelOperOXiDase activitY analYsis
Isolated neutrophils were resuspended in DMEM, HCM, or S-HCM at a final concentration of 10 × 10 5 cells/mL. Neutrophils were then seeded in recombinant tenascin-C (rTnc)-coated (20 µg/mL; Millipore) or control tissue culture plates for 4 hours
Original article | 291 at 37°C in 5% CO 2 . Supernatants were harvested and mixed in a solution of hydrogen peroxide-sodium acetate and tetra-methyl benzidine (Sigma). The quantity of enzyme degrading in 1 mol/L of peroxide per minute at 25°C was defined as 1 U of myeloperoxidase (MPO) activity.
Data analYsis
Results are presented as means ± standard deviation (SD). Differences between groups were compared using Student t test, and a 2-tailed P value <0.05 was considered significant. Calculations were made using SPSS software (Chicago, IL).
Results
tnc eXpressiOn Was preDOMinantlY Up-regUlateD in steatOtic livers aFter iri
To assess Tnc expression in steatotic livers, we used an established mouse model of steatotic hepatic IRI, in which mice fed with a HFD develop approximately 50% liver steatosis, with macrovesicular triglyceride-rich droplets prior to surgery. (28) In contrast to naïve WT normal livers, in which Tnc expression is minimally detected, (19) Tnc was quite readily noticeable in naïve WT steatotic livers (Fig. 1A) . Moreover, it was significantly increased in steatotic livers after 6 hours and 24 hours after hepatic IRI compared with their lean counterparts (Fig. 1A) . We have used immunofluorescence staining of selected cell markers to identify the sources of Tnc in steatotic liver IRI. As shown in Fig. 1 , triple staining of Tnc, GFAP, and DAPI showed colocalization of Tnc and GFAP in steatotic livers after IRI. Steatotic liver sections also exhibited simultaneous staining of Tnc and α-smooth muscle actin (α-SMA) after reperfusion (not shown). In addition to HSCs, Tnc staining was detected in some scattered endothelial and Kupffer cells in the injured steatotic livers after IRI (Fig. 1B-M) .
lipiD accUMUlatiOn in HepatOcYtes regUlateD tnc eXpressiOn in Hscs
HSCs are considered to be major producers of ECM proteins, (34) and we have confirmed that they were significant sources of Tnc in our liver settings. We then used an established palmitate-induced in vitro fatty liver model to test whether hepatic steatosis can affect Tnc expression by HSCs. In this model, steatotic hepatocytes are generated by incubation with saturated fatty acid palmitate (to induce intracellular lipid accumulation), and their conditioned media (S-HCM) is used for cell stimulation. (33) Triple immunofluorescence staining of DAPI, Tnc, and GFAP showed colocalization of Tnc and GFAP in isolated HSCs, which were also characterized by vitamin A deposition in their cytoplasm ( Fig. 2A-F) . Compared with HSCs incubated with control HCM (conditioned media from nonsteatotic hepatocytes), incubation of HSCs with S-HCM resulted in increased α-SMA (~2-fold; P < 0.05) expression and in a striking up-regulation of Tnc (~4-fold; P < 0.05) levels (Fig. 2G,H) . IL1β is an inflammatory cytokine known to activate HSCs. (35) We observed that lipid accumulation in isolated hepatocytes resulted in a significant increase of IL1β expression (~2.5-fold increase; P < 0.05) in these cells (Fig. 2I) . IL1β was also found to be up-regulated in naïve WT steatotic livers (~3-fold increase; P < 0.05) and in WT steatotic livers after IRI (~1.7-fold increase; P < 0.05) when compared with their respective WT lean counterparts. We next examined whether IL1β is capable of regulating Tnc expression in HSCs using varying concentrations of exogenous IL1β. We observed that IL1β induced Tnc expression by HSCs in a dose-dependent fashion (Fig. 2J) . Moreover, we detected a particularly robust Tnc staining in the IL1β-stimulated HSCs ( Fig. 2K-P) . Taken together, the above results suggest that lipid accumulation in the liver leads to an increase of proinflammatory cytokines such as IL1β that, in turn, favors Tnc overproduction.
tnc DeFiciencY DiD nOt interFere WitH tHe DevelOpMent OF Hepatic steatOsis in HFD-FeD Mice
HFD-fed C57BL/6 mice develop fatty livers resembling human obesity (36) and provide a good model to study steatotic liver IRI. (28) To test whether Tnc deficiency affects the development of hepatic steatosis, Tnc-/-deficient mice and respective Tnc+/+ WT control littermates were fed a HFD for 8 weeks (28) ; Tnc-/-deficient and WT mice developed comparable body weight (Fig. 3A) , liver weight (Fig. 3B) , and liver/body weight ratios (Fig. 3C) . Moreover, Tnc-/-and WT 
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livers showed similar levels of fat deposition (~50%), with predominantly macrovesicular fatty infiltration (MaS) after the feeding period (Fig. 2D-H) and, therefore, revealing that HFD-fed Tnc-/-and WT (Tnc+/+) mice developed comparable levels of liver steatosis.
tnc DeFiciencY iMprOveD steatOtic liver FUnctiOn anD HistOlOgY aFter Hepatic iri
To assess the significance of Tnc overproduction in steatotic liver IRI, we used 8-week HFD-fed Tnc-/-mice and respective WT littermates with approximately 50% hepatic steatosis, predominantly macrovesicular. RT-PCR (Fig. 4A ) and immunohistochemistry ( Fig. 4E-G) confirmed that Tnc was fully deleted in our Tnc-/-mice. In contrast, Tnc deposition was strongly detected in nonparenchymal liver cells of WT MaS control mice before and after hepatic IRI (Fig. 4B-D) . In general, MaS-Tnc-/-mice showed less steatotic liver damage, as evidenced by the significantly reduced serum aminotransaminase levels (U/L) at 6 hours (P < 0.05) and 24 hours (P < 0.05) after hepatic IRI compared with MaS-Tnc+/+ controls (Fig. 5A,B) . The lower aminotransferase levels were associated with improved histological preservation in Tnc-/-steatotic mice. MaS-Tnc-/-livers were characterized by decreased sinusoidal congestion and reduced liver necrosis after reperfusion as compared with the highly damaged fatty controls (Fig. 5C-J) .
tnc DeFiciencY DepresseD leUKOcYte inFiltratiOn anD activatiOn in steatOtic liver iri
Infiltration of Ly6-G neutrophils and Mac-1 leukocytes was clearly depressed in the portal areas of MaSTnc-/-livers at 6 hours (P < 0.05) and 24 hours (P < 0.05) after hepatic IRI compared with controls ( Fig.  6A-J) . In addition, MMP9+ leukocytes were also depressed in the MaS-Tnc-/-livers at 6 hours (P < 0.05) and 24 hours (P < 0.05) after reperfusion (Fig. 6K-O) . The decrease in leukocyte recruitment correlated with reduced levels of proinflammatory tumor necrosis factor α (TNF-α; 24 hours), IL1β (6 and 24 hours), and chemokine (C-X-C motif) ligand 2 (CXCL2; 24 hours) in MaS-Tnc-c-/-livers after reperfusion (Fig. 6P-R) .
tnc pOtentiates tHe eFFect OF steatOtic HepatOcYtes On neUtrOpHil-DeriveD MpO activitY
MPO is the most cytotoxic and abundant enzyme secreted by activated neutrophils (37) and an important Original article | 297 factor in the neutrophil-induced oxidative tissue injuries. (38) To test whether Tnc affects MPO activity, neutrophils were incubated with DMEM, HCM, or S-HCM in rTnc-coated or control tissue culture plates. In general, MPO activity was enhanced in neutrophils stimulated by conditioned media from both nonsteatotic (HCM) and steatotic (S-HCM) hepatocytes compared with neutrophils cultured in DMEM.
On the other hand, Tnc up-regulated MPO activity in all 3 groups (DMEM, HCM, and S-HCM) of treated neutrophils. However, its effect was particularly noticeable when neutrophils were incubated simultaneously with Tnc and S-HCM (Fig. 7A) . Indeed, the difference in MPO activity between rTnc (+) and rTnc (-) in the S-HCM group was approximately 2.5-fold larger (P < 0.05) than the equivalent difference in the Fig. 7 . Tnc accentuated the effect of steatotic hepatocytes on neutrophil-derived MPO activity. (A) MPO activity was enhanced in neutrophils stimulated by conditioned media from both nonsteatotic (HCM) and steatotic (S-HCM) hepatocytes compared with neutrophils cultured in DMEM. MPO activity was also elevated in all 3 neutrophil groups (DMEM, HCM, and S-HCM) when cultured in rTnc-coated plates (filled bars) compared with neutrophils cultured in control plates (open bars). However, MPO activity was predominantly increased in neutrophils stimulated by conditioned medium from steatotic hepatocytes in the presence of Tnc. (B) The difference in MPO activity between neutrophils cultured in rTnc-coated plates and neutrophils cultured in control plates in the S-HCM group was approximately 2.5-fold larger than the equivalent difference in the HCM group (in vitro data are expressed as mean ± SD of 3 independent experiments; *P < 0.05).
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HCM group (Fig. 7B) , providing an evidence that Tnc enhances neutrophil-mediated injury in steatotic livers.
Discussion
Here we tested the role of Tnc expression in a model of steatotic hepatic IRI. In this model, mice fed with a steatosis-inducing diet develop approximately 50% liver steatosis, with macrovesicular triglyceride-rich droplets, prior to warm hepatic IRI. (28) The prevalence of obesity has increased substantially in the last 3 decades, (39) and hepatic steatosis, a major complication of obesity, is associated with higher rates of primary nonfunction and to inferior patient survival after surgery. (12, 13) Indeed, the decision about whether or not to transplant a liver is often based on the degree of hepatic steatosis at the time of procurement. (40) Along with transplantation, steatosis has a negative impact in other clinical situations, such as shock and cardiac arrest, which are also subject to warm hepatic IRI. (6, 41) Organ steatosis leads to changes in ECM microenvironments, (42, 43) which are still poorly understood due to their complexity. (21) Tnc is an ECM molecule with a highly restricted expression during embryonic development, and it is virtually undetectable in mostly healthy adult tissues. (15) However, de novo expression of Tnc has been detected in several adult tissues under various pathophysiological conditions. (15, 26) In contrast to naïve normal (lean) livers, in which Tnc protein deposition is nearly absent, (19) Tnc was already readily detected in the vascular areas of naïve steatotic livers. Moreover, Tnc expression was significantly up-regulated in steatotic livers after hepatic IRI when compared with their lean counterparts. HSCs are regarded as key sources of ECM proteins (34) and eagerly expressed Tnc in our liver settings. In addition to HSCs, scattered endothelial and Kupffer cells also stained positively for Tnc during hepatic IRI. To support the hypothesis that steatosis affects the expression of Tnc in the liver, we used a well-established palmitate-induced in vitro fatty liver model, (33) in which hepatocellular lipid accumulation resulted in increased HSC activation and Tnc overproduction by isolated HSCs. IL1β is a proinflammatory cytokine known to activate HSCs, (44) and it was significantly up-regulated in the settings of hepatic steatosis. Indeed, exogenous administration of IL1β induced Tnc production by HSCs in a dose-dependent fashion. Taken together, these findings support the concept that lipid accumulation in hepatocytes, likely through up-regulation of proinflammatory cytokines, leads to an inflated production of Tnc in the liver.
To assess the significance of Tnc expression in steatotic liver IRI, we fed Tnc-/-deficient mice and Tnc+/+ WT littermates with a HFD diet prior to 60 minutes of hepatic ischemia followed by reperfusion. Mice genetically lacking Tnc have no grossly phenotypic abnormalities. (45) Tnc deficiency did not interfere with the ability of mice to develop steatosis; both Tnc-/-and Tnc+/+ HFD-fed mice developed extensive hepatic steatosis, with macrovesicular fat inclusions, after the feeding period. Lack of Tnc expression significantly protected against steatotic hepatic IRI; Tnc-/-steatotic livers were characterized by decreased sinusoidal congestion, reduced necrosis, and improved function after hepatic IRI. We have previously shown that Tnc deficiency is effective in lowering transaminase levels and liver damage at 24 hours after hepatic IRI in normal mice, but it does not significantly affect liver function or damage in the early hours (6 hours) of reperfusion in these mice. (19) Rather remarkably, Tnc deficiency significantly depressed the transaminase levels and enhanced liver histological preservation at both 6 and 24 hours after reperfusion in steatotic mice. Tnc activity is regulated by its production and availability in the extracellular microenvironments. (26) These observations suggest that the increased production of Tnc observed in steatotic livers contributes toward a more prominent role for Tnc in these livers and, therefore, to a more noticeable impact for Tnc deficiency in steatotic hepatic IRI.
Leukocyte transmigration across endothelial and ECM barriers is dependent on adhesive events and matrix degradation mechanisms. (46) Tnc is a ligand for several integrin receptors present on leukocytes. (47) In steatotic livers, leukocyte recruitment and ensuing release of proinflammatory cytokines were significantly depressed after hepatic IRI when Tnc was deleted. These results are in line with growing evidence that local expression of Tnc acts as an important trigger for leukocyte recruitment. (25) It is well accepted that neutrophils are major effectors in innate immune responses and are among the first leukocytes to accumulate in tissues during acute inflammation. (48) Neutrophils release several enzymes upon activation, being MPO the most cytotoxic and abundant enzyme secreted by these cells. (37) In addition to triggering neutrophil recruitment, Tnc regulated neutrophil-derived MPO activity. Besides, the up-regulation of MPO activity was particularly effective when neutrophils were simultaneously exposed to Tnc and conditioned medium from steatotic hepatocytes. MPO activity is an important factor in the neutrophil-induced oxidative tissue injuries, (38) and steatotic livers are particularly susceptible to oxidative stress. (49) MPO generates hypochlorous acid from H 2 O 2 and chloride ions, which is a potent oxidant. (50) Taken all together, these observations support the view that the increased amounts of Tnc in steatotic livers favor a prominent inflammatory milieu in these livers during hepatic IRI. Hence, our results suggest that inhibition of Tnc is a promising therapeutic strategy to curb excessive inflammation in suboptimal steatotic livers and to maximize their successful use in organ transplantation. In addition to hepatic IRI, Tnc has been considered a viable therapeutic candidate for targeting in several other inflammatory pathologies. (22) However, this field is still in its infancy, and more studies aimed at better understanding the biological complexity of Tnc, combined with technological advancements, are needed to generate improved therapeutic modalities to inhibit Tnc in both experimental and clinical settings. (22) reFerences
